Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenter study with an implantable device for atrial therapy

Journal of Cardiovascular Electrophysiology

Volumn 12, Issue 10, 2001, Pages 1121-1128

  Israel, Carsten W ^a   Hügl, Burkhard ^b   Unterberg, Christina ^c   Lawo, Thomas ^d   Kennis, Ingrid ^e   Hettrick, Douglas ^e   Hohnloser, Stefan H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Herzzentrum   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e MEDTRONIC INC   (United States)

Author keywords

Antitachycardia pacing; Atrial fibrillation; Atrial flutter; Dual chamber pacing; Overdrive pacing; Pacemaker algorithm; Pacemaker diagnostics

Indexed keywords

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; ELECTROGRAPHY; FEMALE; HEART ATRIUM PACING; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RELIABILITY; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL RATE;

EID: 0034770736     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2001.01121.x     Document Type: Article

References (39)

1. Prevalence, age distribution, and gender of patients with atrial fibrillation
2. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study
3. Epidemiologic features of chronic atrial fibrillation: The Framingham Study
4. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study
5. Incidence of atrial arrhythmia in patients with long term dual-chamber pacemakers. Contribution of the Holter function of pacemakers
6. Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation
7. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
8. Detection of atrial fibrillation and flutter by a dual chamber implantable cardioverter-defibrillator
9. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator
10. Longitudinal data analysis using generalized linear models
11. Models for longitudinal data: A generalized estimation equation approach
12. A new pacing algorithm for overdrive suppression of atrial fibrillation
13. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive
14. Entrainment and interruption of atrial flutter with atrial pacing: Studies in man following open heart surgery
15. Clinical utility and the predictors of outcome of overdrive transesophageal atrial pacing in the treatment of atrial flutter
16. Regional control of atrial fibrillation by rapid pacing in conscious dogs
17. Regional entrainment of atrial fibrillation studied by high resolution mapping in open chest dogs
18. Failure of single- and multisite high-frequency atrial pacing to terminate atrial fibrillation
19. Atrial overdrive pacing for reversion of atrial flutter after heart transplantation
20. Overdrive atrial pacing for conversion of atrial flutter: Comparison of postoperative with nonpostoperative patients
21. Atrial flutter. 1. Electrophysiologic substrates and modes of initiation and termination
22. Prospective evaluation of transesophageal pacing for the interruption of atrial flutter
23. Efficacy of intravenous propafenone in termination of atrial flutter by overdrive transesophageal pacing previously ineffective
24. Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm
25. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing
26. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in ibe reentrant circuit
27. Electrophysiologic effect of class I and class III antiarrhythmic drugs on typical atrial flutter. Insights into the mechanism of termination
28. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat. Effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol
29. Clinical experience with implantable atrial and combined atrioventricular defibrillators
30. Spontaneous episodes of atrial fibrillation after implantation of the Metrix atrioverter: Observations on treated and nontreated episodes
31. Influence of autothreshold sensing and sinus rate on mode switching algorithm behavior
32. Clinical results of a new automatic mode switch: The "x out of y" concept
33. Diagnostic value of stored electrograms in single-lead VDD systems
34. Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery
35. Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery
36. Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery
37. Permanent overdrive atrial pacing in the chronic management of recurrent postoperative atrial reentrant tachycardia in patients with complex congenital heart disease
38. Prevention of recurrent atrial fibrillation with chronic dualsite right atrial pacing
39. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation